|
1
|
Hill JA and Olson EN: Cardiac plasticity.
N Engl J Med. 358:1370–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abraham WT, Fonarow GC, Albert NM, Stough
WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW and
Young JB: OPTIMIZE-HF Investigators and Coordinators: Predictors of
in-hospital mortality in patients hospitalized for heart failure:
Insights from the Organized Program to Initiate Lifesaving
Treatment in Hospitalized Patients with Heart Failure
(OPTIMIZE-HF). J Am Coll Cardiol. 52:347–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yancy CW, Jessup M, Bozkurt B, Butler J,
Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi
JL, et al: 2013 ACCF/AHA guideline for the management of heart
failure: Executive summary: A report of the American College of
Cardiology Foundation/American Heart Association Task Force on
practice guidelines. Circulation. 128:1810–1852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Savoia C, Burger D, Nishigaki N, Montezano
A and Touyz RM: Angiotensin II and the vascular phenotype in
hypertension. Expert Rev Mol Med. 13:e112011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Small EM and Olson EN: Pervasive roles of
microRNAs in cardiovascular biology. Nature. 469:336–342. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: A typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seok HY, Chen J, Kataoka M, Huang ZP, Ding
J, Yan J, Hu X and Wang DZ: Loss of microRNA-155 protects the heart
from pathological cardiac hypertrophy. Circ Res. 114:1585–1595.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heymans S, Corsten MF, Verhesen W, Carai
P, van Leeuwen RE, Custers K, Peters T, Hazebroek M, Stöger L,
Wijnands E, et al: Macrophage microRNA-155 promotes cardiac
hypertrophy and failure. Circulation. 128:1420–1432. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sethupathy P, Borel C, Gagnebin M, Grant
GR, Deutsch S, Elton TS, Hatzigeorgiou AG and Antonarakis SE: Human
microRNA-155 on chromosome 21 differentially interacts with its
polymorphic target in the AGTR1 3′ untranslated region: A mechanism
for functional single-nucleotide polymorphisms related to
phenotypes. Am J Hum Genet. 81:405–413. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marian AJ: Experimental Therapies in
Hypertrophic Cardiomyopathy. J Cardiovasc Transl Res. 2:483–492.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC,
Zhu LM, Zhu DL, Gao PJ, et al: MicroRNA-155 regulates angiotensin
II type 1 receptor expression and phenotypic differentiation in
vascular adventitial fibroblasts. Biochem Biophys Res Commun.
400:483–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng W, Liu T, Jiang F, Liu C, Zhao X,
Gao Y, Wang H, Liu Z, et al: microRNA-155 regulates angiotensin II
type 1 receptor expression in umbilical vein endothelial cells from
severely pre-eclamptic pregnant women. Int J Mol Med. 27:393–399.
2011.PubMed/NCBI
|
|
13
|
Gómez AM, Ruiz-Hurtado G, Benitah JP and
Domínguez-Rodríguez A: Ca(2+) fluxes involvement in gene expression
during cardiac hypertrophy. Curr Vasc Pharmacol. 11:497–506. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hogan PG, Chen L, Nardone J and Rao A:
Transcriptional regulation by calcium, calcineurin, and NFAT. Genes
Dev. 17:2205–2232. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Varkonyi-Gasic E1, Wu R, Wood M, Walton EF
and Hellens RP: Protocol: A highly sensitive RT-PCR method for
detection and quantification of microRNAs. Plant Methods. 3:122007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Saris JJ, 't Hoen PA, Garrelds IM, Dekkers
DH, den Dunnen JT, Lamers JM and Jan Danser AH: Prorenin induces
intracellular signaling in cardiomyocytes independently of
angiotensin II. Hypertension. 48:564–571. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cavallero S, González GE, Puyó AM, Rosón
MI, Pérez S, Morales C, Hertig CM, Gelpi RJ and Fernández BE:
Atrial natriuretic peptide behaviour and myocyte hypertrophic
profile in combined pressure and volume-induced cardiac
hypertrophy. J Hypertens. 25:1940–1950. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haddad F, Qin AX, Bodell PW, Zhang LY, Guo
H, Giger JM and Baldwin KM: Regulation of antisense RNA expression
during cardiac MHC gene switching in response to pressure overload.
Am J Physiol Heart Circ Physiol. 290:H2351–H2361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lunde IG, Kvaløy H, Austbø B, Christensen
G and Carlson CR: Angiotensin II and norepinephrine activate
specific calcineurin-dependent NFAT transcription factor isoforms
in cardiomyocytes. J Appl Physiol. 111:1278–1289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marian AJ: Hypertrophic cardiomyopathy:
From genetics to treatment. Eur J Clin Invest. 40:360–369. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeppesen PL, Christensen GL, Schneider M,
Nossent AY, Jensen HB, Andersen DC, Eskildsen T, Gammeltoft S,
Hansen JL and Sheikh SP: Angiotensin II type 1 receptor signalling
regulates microRNA differentially in cardiac fibroblasts and
myocytes. Br J Pharmacol. 164:394–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sayed D, Hong C, Chen IY, Lypowy J and
Abdellatif M: MicroRNAs play an essential role in the development
of cardiac hypertrophy. Circ Res. 100:416–424. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:D68–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Seok HY, Tatsuguchi M, Callis TE, He A, Pu
WT and Wang DZ: miR-155 inhibits expression of the MEF2A protein to
repress skeletal muscle differentiation. J Biol Chem.
286:35339–35346. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rinne A and Blatter LA: Activation of
NFATc1 is directly mediated by IP3 in adult cardiac myocytes. Am J
Physiol Heart Circ Physiol. 299:H1701–H1707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Izumi Y, Kim S, Zhan Y, Namba M, Yasumoto
H and Iwao H: Important role of angiotensin II-mediated c-Jun
NH(2)-terminal kinase activation in cardiac hypertrophy in
hypertensive rats. Hypertension. 36:511–516. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Wilkins BJ, Lee YJ, Ichijo H and
Molkentin JD: Direct interaction and reciprocal regulation between
ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.
Mol Cell Biol. 26:3785–3797. 2006. View Article : Google Scholar : PubMed/NCBI
|
